Corporate Members

Diamond Elite





Latest News

taiho oncology

Taiho Oncology Announces Positive Topline Results from Pivotal Phase 3 Trial of LONSURF® (trifluridine/tipiracil) in Metastatic Gastric Cancer

PRINCETON, N.J., May 9, 2018 – Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), and Servier, announced today that the pivotal Phase 3 (TAGS) trial evaluating LONSURF ® (trifluridine and tipiracil) plus best supportive care (BSC) versus placebo plus BSC in patients with previously treated metastatic gastric cancer, met its primary...

Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA

RETACRIT, the First U.S. Biosimilar Erythropoiesis-Stimulating Agent (ESA), Now Approved Across All Indications NEW YORK, N.Y., May 15 – Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the reference product. RETACRIT is now...

Florida Cancer Specialists & Research Institute Announces New Cancer Center in Ocala

Ocala, FL, May 17th, 2018… On May 16th, 2018, at 8:00 am, Florida Cancer Specialists (FCS) celebrated a new state-of-the-art cancer center that will be located on SW 48th Ave (off SR 200), Ocala, Florida 34474. With shovels in hand, FCS Executive Management, staff and Marion County physicians, Drs. Patrick Acevedo, Shilpa Oberoi, Vipul Patel, Craig Reynolds, Sachin Kamath and Mohammad Kamal, kicked off the transformation...

Florida Cancer Specialists Foundation Hosts Golf Classic

Fort Myers, FL – May 16th, 2018… The Florida Cancer Specialists (FCS) Foundation is proud to announce the inaugural 2018 Golf Classic, which will be held May 17th-18th, 2018, at the Heritage Palms Golf & Country Club located at 10420 Washingtonia Palm Way, Fort Myers, FL 33966. The event will be chaired by FCS Physician, Dr. Michael Raymond. The event will include...

Dr. Gail Wright Co-Authors Study on Combination Therapy for Patients with Advanced HER2-Negative Breast Cancer

New Port Richey, FL – May 14, 2018…… Dr. Gail Wright, who practices at Florida Cancer Specialists (FCS) locations in Hudson and New Port Richey was a co-author of a study manuscript recently published online in Breast Cancer Research and Treatment. The study investigated the use of ruxolitinib (an oral targeted therapy drug) or placebo in combination with capecitabine (a chemotherapy drug...

Who’s Online

Profile picture of FLASCO